Fidelity International’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-127,060
Closed -$2.31M 850
2021
Q2
$2.31M Sell
127,060
-298,851
-70% -$6.97M ﹤0.01% 695
2021
Q1
$9.62M Sell
425,911
-104,271
-20% -$2.35M 0.01% 531
2020
Q4
$10.6M Buy
530,182
+356,688
+206% +$7.47M 0.01% 475
2020
Q3
$4.24M Buy
173,494
+164
+0.1% +$3.83K 0.01% 548
2020
Q2
$4.12M Sell
173,330
-833,800
-83% -$19.3M 0.01% 532
2020
Q1
$17.3M Buy
+1,007,130
New +$18.4M 0.03% 385

Other funds holding EXEL

Fidelity International's EXEL Position: Q3 2021 in Review

Fidelity International sold out of Exelixis (EXEL) in Q3 2021, closing a stake of 127,060 shares — an estimated $2.31M sold.

Fidelity International first reported a position in EXEL in Q1 2020 and held it in 6 quarters. The position peaked at $17.3M in Q1 2020. 339 funds tracked by Wall St. Rank hold EXEL as of Q3 2021.

  • Fidelity International reported no remaining Exelixis position as of Q3 2021 after selling out during the quarter.
  • Fidelity International sold 127,060 Exelixis shares in Q3 2021, an estimated $2.31M.
  • Fidelity International first reported a position in Exelixis in Q1 2020 and held it in 6 quarters.
  • Fidelity International's Exelixis position peaked at $17.3M in Q1 2020.
  • 339 funds tracked by Wall St. Rank held Exelixis as of Q3 2021.

Based on Fidelity International's 13F filing for Q3 2021, filed 15 Nov 2021.